Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Urinary Tract Calculi III: Medical Management

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

Urinary Bladder

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...

Cholinergic Antagonists: Pharmacokinetics

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Semon Lectures and the foundation of modern ENT.

The Journal of laryngology and otology·2021

Same author

Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms.

Trials·2021

Same author

Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED.

Current urology reports·2020

Same author

Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial.

Trials·2015

Same author

Durable improvements in urinary incontinence and positive treatment response in patients with idiopathic overactive bladder syndrome following long-term onabotulinumtoxinA treatment: Final results of 3.5-year study.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015

Same author

Nocturia: risk factors and associated comorbidities; findings from the EpiLUTS study.

International journal of clinical practice·2015

Search research articles

Related Experiment Videos

New once-daily formulation for trospium in overactive bladder.

¹Royal Hallamshire Hospital, Sheffield, UK.

International Journal of Clinical Practice

|September 18, 2010

Summary

Trospium chloride, particularly the 60 mg extended-release formulation, is an effective and safe treatment for overactive bladder (OAB). It offers fewer central nervous system effects and drug interactions compared to other antimuscarinic agents.

Area of Science:

Pharmacology and clinical therapeutics
Urology and geriatrics

Background:

Overactive bladder (OAB) is a common condition requiring effective treatment.
Antimuscarinic agents are a mainstay for OAB management, but concerns exist regarding side effects and drug interactions.

Purpose of the Study:

To compare the efficacy and safety of trospium chloride formulations (20 mg bid and 60 mg extended-release) against other antimuscarinic agents for OAB.
To evaluate trospium's unique pharmacokinetic and pharmacodynamic properties.

Main Methods:

Literature review of trospium chloride pharmacology, pharmacokinetics, and clinical studies in OAB patients.
Comparative analysis of efficacy and safety data for trospium formulations and other antimuscarinic drugs.

Main Results:

Related Experiment Videos

Trospium chloride, as a quaternary amine, does not cross the blood-brain barrier, reducing central nervous system side effects.
Minimal liver metabolism via cytochrome pathways leads to a low risk of drug-drug interactions.
Trospium 60 mg ER demonstrated comparable efficacy to 20 mg bid with a lower incidence of dry mouth.
Overall efficacy and safety are comparable to other marketed antimuscarinic agents.

Conclusions:

Trospium chloride, especially the extended-release formulation, is a viable treatment option for OAB, particularly in the elderly.
Its favorable safety profile, including reduced cognitive side effects, makes it a valuable alternative.
Patient persistence with trospium treatment has been reported positively.